ACUTAAS CHEMICALS
|
The Current P/E Ratio of ACUTAAS CHEMICALS is 69.40.
| Share Price | ₹3,282.4 | Aug 10,2026 |
| Market Cap | ₹26,882.4 Cr | |
| Earnings-TTM | ₹387.4 Cr | TTM-Consolidated Results |
| Price/Earnings | 69.40x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ACUTAAS CHEMICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹26,882.4 Cr] as on Aug 10,2026
(/) Earnings [ ₹387.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 69.40x ]
Thus, for ACUTAAS CHEMICALS , the investors are currently willing to pay 69.40 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ACUTAAS CHEMICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ACUTAAS CHEMICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of ACUTAAS CHEMICALS
PE Ratio Performance Analysis for ACUTAAS CHEMICALS
- ACUTAAS CHEMICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 36.04x.
- ACUTAAS CHEMICALS 's operated at median p/e ratio of 47.18x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ACUTAAS CHEMICALS 's p/e ratio peaked in Mar2025 at 62.97x.
- ACUTAAS CHEMICALS 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does ACUTAAS CHEMICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ACUTAAS CHEMICALS | 387.35 | 69.40 | 26,882.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 38.49 | 468,530.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 75.10 | 219,675.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 86.72 | 186,970.0 |
| CIPLA LTD | 3,364.84 | 35.05 | 117,947.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 30.48 | 96,601.2 |
| MANKIND PHARMA LTD | 2,055.11 | 48.99 | 100,688.0 |
| LUPIN LTD | 5,551.01 | 18.74 | 104,021.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 22.24 | 111,790.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 25.51 | 94,707.2 |
| LAURUS LABS LTD | 1,090.76 | 92.43 | 100,822.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ACUTAAS CHEMICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.74x |
| Max industry PE | 92.43x |
| Median industry PE | 38.49x |
| Average industry PE | 49.38x |
You may also like the below Video Courses